Our mission is to produce effective agents with minimal or no toxicity and broad therapeutic properties.

 

We are capitalizing on a newly discovered mechanism of action that helps guide the rational synthesis of new classes of compounds.

 

Our ongoing extensive preclinical testing is advancing lead compounds towards early clinical studies to obtain proof-of-concept.